AGP Executive Report
Last update: 6 hours agoDrug Safety Watch: Taiwan’s TFDA ordered a recall of 87,360 tablets of Beniel F.C. Tablets 8 mg after stability testing showed the pills may not dissolve as required, potentially affecting effectiveness; the recall must be finished by Aug. 24. Medication Risk Alert: A large observational study in the British Journal of Ophthalmology linked long-term tadalafil use (often for urinary symptoms) with higher odds of glaucoma and elevated eye pressure, urging regular eye monitoring for at-risk patients. Mental Health in Chronic Disease: Research from Chang Gung Memorial Hospital found anxiety symptoms in severe CRSwNP patients were tied to higher SNOT-22 scores, eosinophil levels, and comorbid asthma—highlighting the need to screen quality-of-life and mood alongside sinus care. Hospital Workforce Tech: China Medical University Hospital plans to price its care robot (EirBot) below nurse hiring costs to ease staffing strain, with early deployments aimed at taking on standardized nursing tasks like education, documentation support, and item delivery. Public Health Timing: Taiwan CDC expects flu cases to peak in mid-September, while reporting 14 COVID-19 deaths over the past 7 days. Wellness & Lifestyle: A new piece promotes blue light blocking glasses for heavy screen users, focusing on comfort and evening sleep support. Health Tech & Research: Taiwan’s NTHU reported a dual-gate mechanism controlling calcium in cells in PNAS, adding to the science behind disease biology.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.